Therapeutically-loaded autologous extracellular vesicles as a lowly-immunogenic gene therapy for the treatment of age-related macular degeneration.

Researchers

Grant status

Completed-Pending Reports

Grant start date

01/08/2021

Grant funding

  • 2021: $22,641 from Macular Disease Foundation Australia
  • 2022: $22,641 from Macular Disease Foundation Australia

Updated:  23 April 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers